poisar

Stocks · News reference

Niki BioSolutions Subsidiary DiamiR Biosciences Receives NYSDOH Approval for Expanded APOE Genotyping Specimen Types

Fiscal.ai

Niki BioSolutions, Inc. announced that its subsidiary, DiamiR Biosciences Corp., received approval from the New York State Department of Health to expand the specimen types for its APOE Genotyping test.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Niki BioSolutions, Inc. (NIKI)

    Filed: 2026-10-13 AccNo: 0001213900-26-109016 Size: 382 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits